Welcome to International Network for Natural Sciences | INNSpub

Paper Details

Research Paper | March 1, 2014

VIEWS 1
| Download

Protective effect of selenium supplementation on antioxidant defence and cardiovascular diseases in alloxan diabetic rats

S.Boussekine, N.Bouzerna, R.Rouabhi

Key Words: Selenium, Diabetes, Cardiovascular diseases, Oxidative stress, Rats, Alloxan


Int. J. Biosci.4(5), 1-10, 2014

DOI: http://dx.doi.org/10.12692/ijb/4.5.1-10

Certification:

IJB 2014 [Generate Certificate]

Abstract

VIEWS 1

Copyright © 2014
By Authors and International Network for
Natural Sciences (INNSPUB)
http://innspub.net
This article is published under the terms of the Creative
Commons Attribution Liscense 4.0

Protective effect of selenium supplementation on antioxidant defence and cardiovascular diseases in alloxan diabetic rats

Aebi. 1984. Catalase . In L. Packer (Ed), methods in enzymology, Academic press, Orlando, 105: 121-126.

Altan  VM.  2003.  The  pharmacology  of  diabetic complications. Current Medicinal Chemistry 10, 1317– 1327. DOI: 10.2174/0929867033457287

Assmann G, Schulte H. 1988. The  Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease, American Heart Journal. 116, 1713–1724. DOI: 10.1016/0002-8703(88)90220-7

Ayaz M, Ozdemir S, Ugur M, Vassort G and Turan B. 2004. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat, Arch. Biochemistry and Biophysics. 426, 83–90. doi: 10.1016/j.abb.2004.04.008

Ayaz M, Can B, Ozdemir S and Turan B. 2002. Protective effect of selenium treatment on diabetes-induced myocardial structural alterations, Biological Trace Element Research. 89, 215–226. DOI: 10.1385/BTER:89:3:215

Battell M L,  Delgatty H L M and McNeill J H. 1998. Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats, Molecular. Cellular Biochemistry. 179, 27–34. DOI: 10.1023/A:1006819227506

Becker DJ, Reul B, Ozcelikay A, Buchent J P, Henquin JC and Brichard SM. 1996. Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzyme in diabetic rats. Diabetologia; 39, 3-11. DOI: 10.1007/BF00400407

Berg EA, Wu JY, Compbell L, Kagey M And Stapleton SR. 1995. Insulin like effect of vanadate and selenate on the expression of G6PD and fatty acid synthase in diabetic rats. Biochemistry, 77, 919-924.

Bidlack WR. 1996. Interrelationships of food, nutrition health: the National Association of State Universities and Land Grant Colleges White Paper. American Journal of Nutrition. 15, 422–33.

Bradford M. 1976. A rapid and sensitive method for the quantities of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochemistry, 72:248–54. doi:10.1016/0003-2697(76)90527-3

Buccolo G, Harold D. 1973. Quantitative determination of serum triglycerides by use of enzymes. Clinical Chemistry. 19(5), 476-482.

Buege JA, Aust SD. 1984. Microsomal lipid peroxidation. Methods Enzymol, 105:302-310.

Charpentier G. 2002. Oral combination therapy for type 2 diabetes. Diabetes and Metabolism Research and Reviews. 18 (Suppl3), S70– S76.

Ding H, Pen R., Chen J. 1997. Effect of selenite and allitridi on the diabetic mice. Acta Nutr. Sini. 19: 384–387.

Doi K, Sawada F, Toda G. 2001. Alteration of antioxidants during the progression of heart disease in streptozotocin-induced diabetic rats, Free Radical Research. 34(3), 251–261. doi:10.1080/10715760100300231

Ezaki O. 1990. The insulin-like effects of selenate in rat adipocytes, Journal of Biololy and Chemistry. 265, 1124–1130.

Flohe , Gunzler . 1984.  Analysis  of  glutathione peroxidase, Methods Enzymol. 105, 114–121.

Friedewald WT, Levei RI, Fridrickson DS.1972. Estimation of the concentration of low density lipoproteins cholesterol in plasma without use of the ultra centrifugation. Clinical and Chemical research. 18, 499-502.

Giugliano D, Ceriello A, Paolisso G.1996. Oxidative stress and diabetic vascular complications. Diabetes Care. 19, 257–267.  doi: 10.2337/diacare.19.3.257

Guerrero-Romero F and Rodriguez-Moran M. 2005. Complementary therapies for diabetes: the case of chromium. Magnesium Antioxidants. 36, 250–7.

Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione-S-transferase the first step in mercapturic acid formation. Journal of Biology and Chemistry. 249, 7130–9.

Heart H & Sung C.K. 2003. Insulin-like and non-insulin-like selenium actions in 3T3-L1 adipocytes, Journal of Cellular and Biochemistry. 88, 719–731. Doi: 10.1002/jcb.10395

Hei YJ, Farahbakhshian S, Chen X. 1998. Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes. Molecular and Cellular Biochemistry, 178, 367–375. DOI 10.1023/A:1006819906820

Kaplan A. 1984. Lipids. Journal of Clinical Chemistry, 918-919.

Kaplan A . 1984. Glucose. The C.V Mosby CO. St Louis Toronto. Princelon, Journal of Clinical Chemistry. 1032 -1036.

Koehler H, Peters HJ, Pankau H, Duck H.J. 1988. Selenium in cardiology and angiology. Biological Trace Elements Research. 15, 157–167.

Koller L D and Exon J H. 1986. The two faces of selenium-deficiency and toxicity are similar in animals and man. Vet. Research Journal. 50, 297– 306.

Lohr,GW, Waller HD. 1974. Glucose-6-Phosphate Dehydrogenase.  Method  of Enzymatic  Analysis,3rd Edition- Varlag Chemie, Wehnheim; p.636.

Mak DH, Ip SP, Li PC, Poon MK and Ko K. M. 1996. Alterations in tissue glutathione system in streptozotocin-induced diabetic rats. Molecular and Cellular Biochemistry. 162(2), 153–158. DOI: 10.1007/BF00227543

Maritim AC, Sanders Ra and Watkins JBIII. 2003. Diabetes oxidative stress, and anti oxidant. A review. Biochemistry and Toxicology Journal. 17, 24-38.

McNeill JH, Delgatty HLM and Battell ML. 1991. Insulinlike effects of sodium selenate in streptozotocin-induced diabetic rats, Diabetes 40, 1675–1678. doi: 10.2337/diab.40.12.1675

Naito HK, Kaplan A. 1984. Cholesterol. Clinical and Chemical the C.V Mosby CO. St Louis Toronto. Princeton. 1194-11206 and 437.

Naito HK, Kaplan A. 1984. HDLCholesterol. Clinical and Chemical the C.V Mosby CO. St Louis Toronto. Princeton :1207-1213 and 437.

Ness GC, Zhao Z. and Wiggins L. 1994. Insulin and glucagon modulate hepatic 3-hydroxy-methyl glutaryl-coenzyme A. Journal of Biological Chemistry. 269, 29168-29172.

Neve J. 1991. Physiological and nutritional importance of selenium, Experienta 47, 187–193.

Odetti P, Travers ON, Cosso,L, Noberasco G, Pronzato MA and Marinariu M. 1996. Good glycemic control reduces oxidation and glycation end-products in collagen of diabetic rats. Diabetologia. 39, 1440-1447. DOI: 10.1007/s001250050596

Opie LH. 1970. Effect of fatty acid on contractility and rhythm of the heart. Nature (London) 227, 1055– 1066.

Rodrigues BB, Goyal RK, McNeill JH. 1986. Effects of hydralazine on streptozotocin induced diabetic rats: Prevention of hyperlipidemia and improvement in cardiac function. Journal of Pharmacological. 237, 292– 299.

Rodrigues BB, McNeill JH. 1986. Cardiac function in spontaneously hypertensive diabetic rats. American Journal of Physiology. 251, H571–H580.

Rosen P, Du X, Tschope D. 1998. Role of oxygen-derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol, Molecular and Cellular Biochemistry. 188, 103–111.

Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafemen DG and Hoekstra WG. 1973. Selenium: biochemical role as a component of glutathione peroxidase, Science 179, 588–590.

Sapin, R. Le Galudec V, Gasser F, Pinget M, Grucker D. 2001. Elecsys insulin Assay; Free Insulin Determination and the absence of Cross-Reactivity with Insulin Lispro. Clinical Chemistry. 47, 602-605.

Stapleton SR, Garlock GL, Foellmi-Adams L. 1997. Selenium potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. Biochemica and Biophysica Acta, 1355, 259–269. DOI: 10.1016/S0167-4889(96)00140-1

Stapleton SR. 2000. Selenium: an insulin mimetic. Cellular and Molecular life Science. 57, 1874-1879. DOI: 10.1007/PL00000669

Strojek K. 2003. Features of macrovascular complications  in  type  2  diabetic  patients. Acta Diabetologica,  40 (Suppl 2),  S334–  S337.  DOI  : 10.1007/s00592-003-0115-x

Suthagar E, Soudamani S, Yuvaraj S ,Ismail khan A, Aruldhas MM, Balasubramanian K. 2009. Effects of streptozotocin induced diabetes and insulin replacement on rat ventral prostate. Biomed pharmacother, 63, 43-50. Doi: 10.1016/j.biopha.2008.01.002

Veki H, Ohkura Y, Moxoyashiki T, Tominage N. and Morita T. 1993. Increase in lipoprotein lipase activity in isolated rat adipose tissue by selenate. Biology and Pharmacology Bull. 16, 6-10.

Weckbercker G, Cory JG. 1988. Ribonucleotide reductase activity and growth of Glutathione-depended mouse Leukemia L1210 cells in vitro. Cancer Letter, 40, 257-264. PMID: 3289734

Zhang, Z, Yu.J and Stanto, RC. 2000. A method for determination of pyridine nucleotides using a single extract. Analytical biochemistry, 285, 163- 167. DOI: 10.1006/abio.2000.4701

Zhong GG, Jiang Y, Li ZB, Zhang BG, Zhang WJ, Yue G. 1990. Protective action of selenium and manganese on xanthine and xanthine oxidase induced oxidative damage to cultured heart cells. Chinese Medical Journal. 103, 735–742. PMID:2123774

SUBMIT MANUSCRIPT

Style Switcher

Select Layout
Chose Color
Chose Pattren
Chose Background